Major League Soccer Chooses OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for Players and Employees

BioReference initiates COVID-19 testing for all Major League Soccer players, match officials, and Club and League employees participating in the MLS is Back Tournament MLS will support COVID-19 antibody testing for the Orlando community utilizing BioReference’s community collection program ELMWOOD PARK, N.J., July 09, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), will […]

OPKO Health’s BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees

Based on internal data, 29% of nursing home employees tested positive for antibodies Since the beginning of the COVID-19 pandemic, BioReference has performed 222,000 COVID-19 PCR and 3,500 antibody tests in over 350 facilities ELMWOOD PARK, N.J., July 1, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR […]

MagnaCare and BioReference Laboratories Bring COVID-19 Antibody Testing to New York Labor Groups

Collaboration supports return-to-work planning for key workforce groups NEW YORK (May 18, 2020) – MagnaCare today announced a collaboration with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), to bring COVID-19 antibody testing to their Labor clients in the New York metropolitan area. Through this collaboration with BioReference, MagnaCare will offer on-site antibody blood […]

OPKO Health’s BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collaboration to Deliver Operational and Diagnostic Services

ELMWOOD PARK, N.J., May 13, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced a strategic collaboration with the Westchester Medical Center Health Network (WMCHealth), a 1,700-bed healthcare system headquartered in Valhalla, New York, to provide full laboratory administrative services, laboratory operations, reference testing and outpatient laboratory services. WMCHealth has 10 hospitals […]

OPKO Health’s BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents

In partnership with NYC Health + Hospitals, BioReference is expanding access to COVID-19 antibody testing ELMWOOD PARK, N.J., May 8, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health […]

OPKO Health’s BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies

BioReference will broaden availability of serological antibody tests to states, hospitals and healthcare organizations throughout the United States ELMWOOD PARK, N.J., April 29, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing […]

OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)

BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]

Novitas Issues Final Local Coverage Determination for the 4Kscore® Test

Medicare coverage for patients meeting certain criteria to begin as of December 30, 2019 MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019.  Full text of the […]

Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services Serving Members of Horizon Healthcare Services, Inc.

MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States, will remain an in-network provider with Horizon Health Services, Inc. (Horizon), New Jersey’s oldest and largest health insurer. After an extensive evaluation of its laboratory network, BRL will remain a preferred laboratory in the Horizon PPO network. The […]